Chelain Goodman, MD PhD

4.9K posts

Chelain Goodman, MD PhD banner
Chelain Goodman, MD PhD

Chelain Goodman, MD PhD

@ChelainG

Assistant Professor of Breast Radiation Oncology at MD Anderson Cancer Center @MDAndersonNews | Passions: translational research & #meded! Opinions are my own.

Houston, TX Beigetreten Ekim 2013
4.6K Folgt4K Follower
Chelain Goodman, MD PhD retweetet
Neha Vapiwala
Neha Vapiwala@NehaVapiwala·
Radiation oncologists are trained to deliver safe, high-precision radiotherapy as part of a #cancer care team. We follow the best available evidence & develop customized, cost-effective plans. Science guides our treatments, but humanity guides our practice. 1/2
ASTRO@ASTRO_org

In the News: ASTRO marks President Biden’s treatment milestone with ASTRO President Neha Vapiwala, MD leading the treatment team. @NehaVapiwala @SameerKeoleMD @PennMedicine @JoeBiden ow.ly/yCUo50XgSQh

English
2
41
239
38.3K
Chelain Goodman, MD PhD retweetet
Adam Grippin
Adam Grippin@adam_grippin·
We looked back at ~1000 patients with lung cancer and melanoma treated with immune checkpoint inhibitors (ICIs). We found that those who happened to received COVID mRNA vaccines within 100 days of starting ICIs lived much longer than those who did not receive the vaccine.
Adam Grippin tweet media
English
1
4
8
1.7K
Chelain Goodman, MD PhD
Chelain Goodman, MD PhD@ChelainG·
Looking forward to discussing the option for repeat breast conservation and re-irradiation for our patients who experience locoregional recurrence at #SABCS25! Couldn’t be more humbled to present alongside @BOffersen and Dr. Broyles in a panel led by @JBStraussMD. @MDAndersonNews
SABCS@SABCSSanAntonio

Refining Local Therapy in Multi-disciplinary Care: Chelain Goodman, Birgitte Offersen, and Justin Broyles will address this topic in an educational session at #SABCS25 (December 9-12). Learn more: brnw.ch/21wUIiH @ChelainG @BOffersen

English
0
0
16
1.4K
Chelain Goodman, MD PhD retweetet
Jane Jomy
Jane Jomy@JaneJomy·
Exciting presentation by Dr. Goodman @ChelainG demonstrating a ⬆️ rate of CTC clearance following neo & adjuvant radiotherapy in non-metastatic T3+ and/or N+ BC - looking forward to the next phase to assess CTC’s potential as a surrogate survival endpoint #ESTRO25 @ESTRO_RT
Jane Jomy tweet media
English
0
1
5
740
Chelain Goodman, MD PhD
Chelain Goodman, MD PhD@ChelainG·
Congrats all for the incredible work getting these important data and valuable resident feedback out for all to see! Great to see so much continued passion for #radonc and #meded! @mustafabasree @baileynelson92 @ARRO_org @roecsg
Mustafa Basree, DO MS | مصطفى بصري@mustafabasree

1/🧵What do graduating #RadOnc residents think about their training? We analyzed 5 years of ARRO data (820 PGY5s; response rate ~87%) — the largest study to date. The good, the no-so-good, and the growing interest in competency based #MedEd @ARRO_org pubmed.ncbi.nlm.nih.gov/40164356/

English
1
2
15
1.3K
Corey Speers
Corey Speers@cwspeers·
Couldn’t be more grateful for amazing colleagues and mentors @UMichRadOnc and @RadOncUH and especially @DrSpratticus. Incredibly humbled and honored to join amazing groups @UABmedphys @UABradonc . Excited for what the future holds for the department, school, community, and field!
UAB Heersink School of Medicine@UABHeersink

After a national search, Corey Speers, M.D., Ph.D., has been named chair of the UAB Department of @UABradonc, effective May 12, 2025. Click the link below to learn more about Dr. Speers! buff.ly/3WqL6WA.

English
43
5
131
15.6K
Chelain Goodman, MD PhD retweetet
AmyMorenoMD
AmyMorenoMD@AmyMorenoMD·
With over 16 classification systems, osteoradionecrosis (ORN) has been a challenging RT-related toxicity to diagnose and manage. I’m excited to share the multidisciplinary ORAL Consortium’s consensus guidelines on standardized data capture to enhance interoperability & diagnosis!
English
2
6
16
1K
Chelain Goodman, MD PhD
Chelain Goodman, MD PhD@ChelainG·
SUPREMO does not answer role of PMRT after SLNB without ALND. - All N+ had ALND - does not address N+ patients s/p SLNB only. - Per AMAROS, PMRT associated with reduced risk of lymphedema vs ALND. So, PMRT still the treatment of choice post SLNB for int risk N+ pts? #SABCS24
Wendy Woodward MDPhD@IBCradiation

Supremo trial 10 yr data PMRT vs not in N0, or 1-3 nodes showing no significant benefit to PMRT for any endpoint/CW benefit significant but small. Important context, all had axlnd. Will future include targeted ax radiation? Does this apply after SLNbx? #SABCS24

English
2
3
15
3.2K
Chelain Goodman, MD PhD retweetet
Angel Montero Luis
Angel Montero Luis@Monthy_A·
Omission reaches also systemic treatments for breast cancer: EUROPA trial preliminary results with superb @Icro_Meattini presentation at #SABCS24 shows RT might be a better approach for women aged 70+ with luminal A-like early breast cancer #radonc #bcsm
Angel Montero Luis tweet mediaAngel Montero Luis tweet mediaAngel Montero Luis tweet mediaAngel Montero Luis tweet media
English
0
13
38
1.8K
Corey Speers
Corey Speers@cwspeers·
Words fail… R.I.P. @felixfengmd We started a lab together, a company together, and he helped me personally and professionally in ways that can’t be measured. The world lost a great one today 😢 thoughts and prayers to @MaryFengMD and her precious kids
Corey Speers tweet mediaCorey Speers tweet mediaCorey Speers tweet mediaCorey Speers tweet media
English
13
10
124
14.4K
Mark Storey
Mark Storey@ProtonStorey·
@ChelainG I dug around - couldn't find it (even through appendix) - I bet you know it - I'm out of loop these days. For those interested, here is the original 2 yr publication from Lancet #app-1" target="_blank" rel="nofollow noopener">thelancet.com/journals/lanon…
English
1
0
1
118